Clinical Trial Update: Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial [Phase 2]

View source ↗

Summary

Intervene Immune, Inc. is conducting a Phase 2 clinical trial focused on thymus regeneration, immunorestoration, and insulin mitigation for conditions related t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epigenetic Aging
• Immunosenescence

Snippet

Sponsor: Intervene Immune, Inc. | Conditions: Epigenetic Aging, Immunosenescence | Phase 2 | Status: RECRUITING